Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 35

1.

Truth in science and in molecular recognition, post-truth in human affairs.

Van Regenmortel MHV.

J Mol Recognit. 2020 Jan;33(1):e2827. doi: 10.1002/jmr.2827. Epub 2019 Dec 3. No abstract available.

PMID:
31797469
2.

Assessing the Dynamics and Complexity of Disease Pathogenicity Using 4-Dimensional Immunological Data.

Rivas AL, Hoogesteijn AL, Antoniades A, Tomazou M, Buranda T, Perkins DJ, Fair JM, Durvasula R, Fasina FO, Tegos GP, van Regenmortel MHV.

Front Immunol. 2019 Jun 12;10:1258. doi: 10.3389/fimmu.2019.01258. eCollection 2019.

3.
4.

Viral species, viral genomes and HIV vaccine design: is the rational design of biological complexity a utopia?

van Regenmortel MHV.

Arch Virol. 2018 Aug;163(8):2047-2054. doi: 10.1007/s00705-018-3955-y. Epub 2018 Jul 26. Review.

PMID:
30051341
5.

The Species Problem in Virology.

Van Regenmortel MHV.

Adv Virus Res. 2018;100:1-18. doi: 10.1016/bs.aivir.2017.10.008. Epub 2017 Nov 2.

PMID:
29551132
6.

Development of a Preventive HIV Vaccine Requires Solving Inverse Problems Which Is Unattainable by Rational Vaccine Design.

Van Regenmortel MHV.

Front Immunol. 2018 Jan 12;8:2009. doi: 10.3389/fimmu.2017.02009. eCollection 2017.

7.

Nature and Consequences of Biological Reductionism for the Immunological Study of Infectious Diseases.

Rivas AL, Leitner G, Jankowski MD, Hoogesteijn AL, Iandiorio MJ, Chatzipanagiotou S, Ioannidis A, Blum SE, Piccinini R, Antoniades A, Fazio JC, Apidianakis Y, Fair JM, Van Regenmortel MHV.

Front Immunol. 2017 May 31;8:612. doi: 10.3389/fimmu.2017.00612. eCollection 2017. Review.

8.

Immune systems rather than antigenic epitopes elicit and produce protective antibodies against HIV.

Van Regenmortel MHV.

Vaccine. 2017 Apr 11;35(16):1985-1986. doi: 10.1016/j.vaccine.2017.03.017. Epub 2017 Mar 18. No abstract available.

PMID:
28320589
9.
10.

Commentary: Basic Research in HIV Vaccinology Is Hampered by Reductionist Thinking.

Van Regenmortel MH.

Front Immunol. 2016 Jul 5;7:266. doi: 10.3389/fimmu.2016.00266. eCollection 2016. No abstract available.

11.

Editorial: Paradigm Changes are Required in HIV Vaccine Research.

Van Regenmortel MH.

Front Immunol. 2015 Jun 23;6:326. doi: 10.3389/fimmu.2015.00326. eCollection 2015. No abstract available.

12.

Why Does the Molecular Structure of Broadly Neutralizing Monoclonal Antibodies Isolated from Individuals Infected with HIV-1 not Inform the Rational Design of an HIV-1 Vaccine?

Van Regenmortel MHV.

AIMS Public Health. 2015 May 6;2(2):183-193. doi: 10.3934/publichealth.2015.2.183. eCollection 2015. Review.

14.

Specificity, polyspecificity, and heterospecificity of antibody-antigen recognition.

Van Regenmortel MH.

J Mol Recognit. 2014 Nov;27(11):627-39. doi: 10.1002/jmr.2394. Review.

PMID:
25277087
15.

More Surprises in the Development of an HIV Vaccine.

Esparza J, Van Regenmortel MH.

Front Immunol. 2014 Jul 14;5:329. doi: 10.3389/fimmu.2014.00329. eCollection 2014. No abstract available.

16.

Virus species polemics: 14 senior virologists oppose a proposed change to the ICTV definition of virus species.

Van Regenmortel MH, Ackermann HW, Calisher CH, Dietzgen RG, Horzinek MC, Keil GM, Mahy BW, Martelli GP, Murphy FA, Pringle C, Rima BK, Skern T, Vetten HJ, Weaver SC.

Arch Virol. 2013 May;158(5):1115-9. doi: 10.1007/s00705-012-1583-5. Epub 2012 Dec 27.

PMID:
23269443
17.

Basic research in HIV vaccinology is hampered by reductionist thinking.

Van Regenmortel MH.

Front Immunol. 2012 Jul 9;3:194. doi: 10.3389/fimmu.2012.00194. eCollection 2012.

18.

Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine.

Van Regenmortel MH.

Arch Virol. 2012 Jan;157(1):1-20. doi: 10.1007/s00705-011-1145-2. Epub 2011 Oct 20. Review.

19.

Two meanings of reverse vaccinology and the empirical nature of vaccine science.

Van Regenmortel MH.

Vaccine. 2011 Oct 19;29(45):7875. doi: 10.1016/j.vaccine.2011.08.063. Epub 2011 Sep 6. No abstract available.

PMID:
21888936
20.

Limitations to the structure-based design of HIV-1 vaccine immunogens.

Van Regenmortel MH.

J Mol Recognit. 2011 Sep-Oct;24(5):741-53. doi: 10.1002/jmr.1116. Review.

PMID:
21812050

Supplemental Content

Loading ...
Support Center